Pharmacologic RNA splicing modulation: a novel mechanism to enhance neoantigen-directed anti-tumor immunity and immunotherapy response

Detalles Bibliográficos
Autores principales: Elliott, Kerryn, Nilsson, Jonas, Van den Eynden, Jimmy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553762/
https://www.ncbi.nlm.nih.gov/pubmed/34711802
http://dx.doi.org/10.1038/s41392-021-00789-9
_version_ 1784591647242190848
author Elliott, Kerryn
Nilsson, Jonas
Van den Eynden, Jimmy
author_facet Elliott, Kerryn
Nilsson, Jonas
Van den Eynden, Jimmy
author_sort Elliott, Kerryn
collection PubMed
description
format Online
Article
Text
id pubmed-8553762
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85537622021-10-29 Pharmacologic RNA splicing modulation: a novel mechanism to enhance neoantigen-directed anti-tumor immunity and immunotherapy response Elliott, Kerryn Nilsson, Jonas Van den Eynden, Jimmy Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2021-10-28 /pmc/articles/PMC8553762/ /pubmed/34711802 http://dx.doi.org/10.1038/s41392-021-00789-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Highlight
Elliott, Kerryn
Nilsson, Jonas
Van den Eynden, Jimmy
Pharmacologic RNA splicing modulation: a novel mechanism to enhance neoantigen-directed anti-tumor immunity and immunotherapy response
title Pharmacologic RNA splicing modulation: a novel mechanism to enhance neoantigen-directed anti-tumor immunity and immunotherapy response
title_full Pharmacologic RNA splicing modulation: a novel mechanism to enhance neoantigen-directed anti-tumor immunity and immunotherapy response
title_fullStr Pharmacologic RNA splicing modulation: a novel mechanism to enhance neoantigen-directed anti-tumor immunity and immunotherapy response
title_full_unstemmed Pharmacologic RNA splicing modulation: a novel mechanism to enhance neoantigen-directed anti-tumor immunity and immunotherapy response
title_short Pharmacologic RNA splicing modulation: a novel mechanism to enhance neoantigen-directed anti-tumor immunity and immunotherapy response
title_sort pharmacologic rna splicing modulation: a novel mechanism to enhance neoantigen-directed anti-tumor immunity and immunotherapy response
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553762/
https://www.ncbi.nlm.nih.gov/pubmed/34711802
http://dx.doi.org/10.1038/s41392-021-00789-9
work_keys_str_mv AT elliottkerryn pharmacologicrnasplicingmodulationanovelmechanismtoenhanceneoantigendirectedantitumorimmunityandimmunotherapyresponse
AT nilssonjonas pharmacologicrnasplicingmodulationanovelmechanismtoenhanceneoantigendirectedantitumorimmunityandimmunotherapyresponse
AT vandeneyndenjimmy pharmacologicrnasplicingmodulationanovelmechanismtoenhanceneoantigendirectedantitumorimmunityandimmunotherapyresponse

Ejemplares similares